0001104659-22-086723.txt : 20220805 0001104659-22-086723.hdr.sgml : 20220805 20220805163113 ACCESSION NUMBER: 0001104659-22-086723 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220804 FILED AS OF DATE: 20220805 DATE AS OF CHANGE: 20220805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martin Tami Tillotson CENTRAL INDEX KEY: 0001539494 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 221141296 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4 1 tm2222645-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-08-04 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001539494 Martin Tami Tillotson C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850 0 1 0 0 Sr. V.P., Regulatory Affairs Common Stock 2022-08-04 4 M 0 5000 7.90 A 92220 D Common Stock 2022-08-04 4 S 0 5000 32.98 D 87220 D Employee Stock Option (Right to Buy) 7.90 2022-08-04 4 M 0 5000 0 D 2023-02-05 Common Stock 5000 5000 D Transaction made pursuant to a 10b5-1 trading plan adopted May 19, 2022. The option vested in four equal annual installments beginning on February 5, 2014. /s/ Timothy C. Dec, as attorney-in-fact 2022-08-05